BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9060842)

  • 1. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
    Marie PJ; de Pollak C; Chanson P; Lomri A
    Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
    Alman BA; Greel DA; Wolfe HJ
    J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein.
    Motomura T; Kasayama S; Takagi M; Kurebayashi S; Matsui H; Hirose T; Miyashita Y; Yamauchi-Takihara K; Yamamoto T; Okada S; Kishimoto T
    J Bone Miner Res; 1998 Jul; 13(7):1084-91. PubMed ID: 9661072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
    Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S
    J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular and molecular biology of fibrous dysplasia].
    Marie P
    Ann Pathol; 2001 Dec; 21(6):489-98. PubMed ID: 11910936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
    Shenker A; Weinstein LS; Sweet DE; Spiegel AM
    J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
    Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
    N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
    Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular basis of fibrous dysplasia.
    Marie PJ
    Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions.
    Kashima TG; Nishiyama T; Shimazu K; Shimazaki M; Kii I; Grigoriadis AE; Fukayama M; Kudo A
    Hum Pathol; 2009 Feb; 40(2):226-37. PubMed ID: 18799196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.
    Candeliere GA; Glorieux FH; Prud'homme J; St-Arnaud R
    N Engl J Med; 1995 Jun; 332(23):1546-51. PubMed ID: 7739708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic studies of fibrous dysplasia.
    Ohira O
    Nihon Seikeigeka Gakkai Zasshi; 1981 May; 55(5):497-507. PubMed ID: 7288235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.
    Riminucci M; Fisher LW; Shenker A; Spiegel AM; Bianco P; Gehron Robey P
    Am J Pathol; 1997 Dec; 151(6):1587-600. PubMed ID: 9403710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome.
    Robey PG; Kuznetsov S; Riminucci M; Bianco P
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():386-94. PubMed ID: 17982385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
    Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.